CLSI EP26-Ed2-IG

User Evaluation of Acceptability of a Reagent Lot Change Implementation Guide, EP26-Ed2-IG

Clinical and Laboratory Standards Institute, 11/01/2022

Publisher: CLSI

File Format: PDF

$25.00$50.00


Published:01/11/2022

Pages:14

File Size:1 file , 920 KB

Note:This product is unavailable in Russia, Belarus

This implementation guide describes the minimum procedures necessary for a medical laboratory to verify that new reagent lots, when received and implemented by the laboratory, will produce results consistent with previous reagent lots. Reagent lot performance is validated by the developer before release and distribution; however, the laboratory needs to verify each new reagent lot it receives. Changes in performance with a new reagent lot could be due to:
• Changes in reagent component materials
• Instability of a component in a reagent
• Reagents that were compromised in transportation or storage
• Incorrect calibration of the new reagent lot

Verifying that these potential changes have not occurred is important to ensure the quality of laboratory results. For additional information on the acceptability of a reagent lot change, see CLSI document EP26.1

More CLSI standard pdf

CLSI M23A2

CLSI M23A2

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline, M23-A2

$109.00 $219.97

CLSI AUTO04-A

CLSI AUTO04-A

Laboratory Automation: Systems Operational Requirements, Characteristics, and Information Elements; Approved Standard, AUTO04AE

$107.00 $214.51

CLSI AUTO05-A

CLSI AUTO05-A

Laboratory Automation: Electromechanical Interfaces; Approved Standard, AUTO05AE

$125.00 $250.90

CLSI AUTO3A

CLSI AUTO3A

Laboratory Automation: Communications with Automated Clinical Laboratory Systems, Instruments, Devices, and Information Systems; Approved Standard, AUTO3-A

$107.00 $215.38